Efficacy of aspirin for stage III colorectal cancer: A randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial).

Atsuo Takashima,Kenichi Miyamoto,Yuya Sato,Natsuko Okita,Manabu Shiozawa,Shigeki Yamaguchi,Ryo Inada,Yusuke Nishizawa,Masayuki Ohue,Nobuhiro Takiguchi,Junki Mizusawa,Hiroshi Katayama,Kenichi Nakamura,Taro Shibata,Haruhiko Fukuda,Yasuhiro Shimada,Yukihide Kanemitsu,Tetsuya Hamaguchi

Efficacy of aspirin for stage III colorectal cancer: A randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial).

2019

Atsuo Takashima
Kenichi Miyamoto
Yuya Sato
Natsuko Okita
Manabu Shiozawa
Shigeki Yamaguchi
Ryo Inada
Yusuke Nishizawa
Masayuki Ohue
Nobuhiro Takiguchi
Junki Mizusawa
Hiroshi Katayama
Kenichi Nakamura
Taro Shibata
Haruhiko Fukuda
Yasuhiro Shimada
Yukihide Kanemitsu
Tetsuya Hamaguchi

TPS3623Background: Adjuvant chemotherapy is the current standard treatment for stage III colorectal cancer after curative resection. However, the prognosis of stage III colorectal cancer is still p...

Keywords:

Placebo-controlled study
Stage III colorectal cancer
Physical therapy
Internal medicine
Medicine
Aspirin
Gastroenterology
double blind
Standard treatment
curative resection
adjuvant chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations